Get started
Author

Y. S. Park

Observed names: Y S Park, Y.S. Park, Ye-Lin Park, Youngjun Park
Observed institutions: Yonsei University, Asan Medical Center, Samsung Medical Center, University of Ulsan, National Cancer Center, Jeju Research Institute, National Cancer Center Hospital, Jeju National University, Sungkyunkwan University
ORCID: 0009-0007-5552-4847
Observed ORCIDs: 0009-0007-5552-4847, 0000-0001-9625-6008
OpenAlex ID: A5109064147
Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
2013 · H K Ahn, J Y Choi, et al. · British Journal of Cancer · 82
PDF
Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer
2009 · J.S. Park, H.K. Kim, et al. · Annals of Oncology · 76
PDF
Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition
2016 · S.T. Kim, S.Y. Kim, et al. · Annals of Oncology · 69
PDF
Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer
2007 · J. Lee, Y. H. Im, et al. · Cancer Chemotherapy and Pharmacology · 62
Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations
2002 · H. K. Kim, K. S. Song, et al. · Blood Coagulation & Fibrinolysis · 62
Genetic influence on bone mineral density in Korean twins and families: the healthy twin study
2011 · J.-H. Park, Y.-M. Song, et al. · Osteoporosis International · 32
Capecitabine Monotherapy in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer
2004 · S.-H. Lee, J. Lee, et al. · Medical Oncology · 32
Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
2004 · S-H Lee, W K Kang, et al. · British Journal of Cancer · 24
PDF
Leveraging natural language processing for efficient information extraction from breast cancer pathology reports: Single-institution study
2025 · Phillip Park, Yeonho Choi, et al. · PLoS ONE · 14
Mortality Prediction Modeling for Patients with Breast Cancer Based on Explainable Machine Learning
2024 · Sang Won Park, Ye-Lin Park, et al. · Cancers · 9
PDF
The adequacy of the distal resection margin after preoperative chemoradiotherapy for rectal cancer
2014 · T. G. Kim, W. Park, et al. · Colorectal Disease · 8
gastrointestinal tumours, colorectal Nintedanib plus best supportive care (BSC) versus placebo plus BSC for the treatment of patients (pts) with colorectal cancer (CRC) refractory to standard therapies: Results of the phase III LUME-colon 1 study
2016 · E. Van Cutsem, T. Yoshino, et al. · Annals of Oncology · 7
Fatigue strength assessment including welding residual stress of spot welded joints subjected to cross-tension loads
2014 · Y. S. Park, I. S. Sohn, et al. · International Journal of Automotive Technology · 7
Phase II trial of irinotecan and capecitabine in patients with advanced colorectal cancer (ACRC)
2005 · J.-B. Ahn, K. H. Jung, et al. · Journal of Clinical Oncology · 5
Phase I clinical study of heptaplatin (H) and paclitaxel (P) in previously treated patients with advanced solid tumor
2004 · K. H. Jung, D. H. Lee, et al. · Journal of Clinical Oncology · 4
Application of a Natural Language Processing Framework for Data Extraction From Pathology Reports Across Multiple Cancer Types
2026 · Phillip Park, Yeonho Choi, et al. · Journal of Korean Medical Science · 1
PDF
Downregulation of CD44 Leads to Therapeutic Resistance and Poor Prognosis in Non-Small Cell Lung Cancer
2013 · C.M. Choi, Y.S. Park, et al. · Annals of Oncology · 1
PDF
Purification of Kudoa septempunctata myxospores by using trypsin and fluorescence activated cell sorting
2026 · Hyun Ki Hong, Youngjun Park, et al. · Parasites Hosts and Diseases
Abstract 783: Exploring landscapes of T cell activation in acidic environment for tumor immunotherapy.
2026 · Minkyeong Ro, Youngjun Park · Cancer Research
Abstract 4667: Targeting ULK1 overcomes autophagy-mediated chemoresistance in cancer cell
2026 · Eun-Jung Kim, Youngjun Park · Cancer Research
LBA30 Zanzalintinib plus atezolizumab (zanza + atezo) vs regorafenib (rego) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): Primary overall survival (OS) analysis from the randomized, open-label, phase III STELLAR-303 study
2025 · A. Saeed, Y.S. Park, et al. · Annals of Oncology
Phase III study of trifluridine/tipiracil versus placebo in Asian patients with metastatic colorectal cancer (TERRA study): Country subgroup
2017 · V. Sriuranpong, T.W. Kim, et al. · Annals of Oncology
Poster session 4. Molecular diagnosis & biomarkers
2013 · J. A. Lynch, C. M. Choi, et al. · Annals of Oncology
Acquired Resistance to 17-DMAG is Mediated by Reduced NQO1 in Lung Cancer with ALK Translocation
2013 · J.C. Lee, J.K. Rho, et al. · Annals of Oncology
PDF
Preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer: Results of a phase II study and the role of apparent diffusion coefficient (ADC) by diffusion-weighted magnetic resonance imaging (DW MRI) for prediction of pathologic responses.
2011 · E. M. Lee, J. L. Hong, et al. · Journal of Clinical Oncology
Works count: 28
Citation count: 495
H-index: 9
I10-index: 9
Year
Topic
Type